Literature DB >> 29738823

When fragments link: a bibliometric perspective on the development of fragment-based drug discovery.

Angelo K S Romasanta1, Peter van der Sijde2, Iina Hellsten3, Roderick E Hubbard4, Gyorgy M Keseru5, Jacqueline van Muijlwijk-Koezen6, Iwan J P de Esch7.   

Abstract

Fragment-based drug discovery (FBDD) is a highly interdisciplinary field, rich in ideas integrated from pharmaceutical sciences, chemistry, biology, and physics, among others. To enrich our understanding of the development of the field, we used bibliometric techniques to analyze 3642 publications in FBDD, complementing accounts by key practitioners. Mapping its core papers, we found the transfer of knowledge from academia to industry. Co-authorship analysis showed that university-industry collaboration has grown over time. Moreover, we show how ideas from other scientific disciplines have been integrated into the FBDD paradigm. Keyword analysis showed that the field is organized into four interconnected practices: library design, fragment screening, computational methods, and optimization. This study highlights the importance of interactions among various individuals and institutions from diverse disciplines in newly emerging scientific fields.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Mesh:

Year:  2018        PMID: 29738823     DOI: 10.1016/j.drudis.2018.05.004

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  10 in total

1.  Comprehensive analysis of commercial fragment libraries.

Authors:  Julia Revillo Imbernon; Célien Jacquemard; Guillaume Bret; Gilles Marcou; Esther Kellenberger
Journal:  RSC Med Chem       Date:  2021-12-24

2.  Dyslexia: A Bibliometric and Visualization Analysis.

Authors:  Yanqi Wu; Yanxia Cheng; Xianlin Yang; Wenyan Yu; Yuehua Wan
Journal:  Front Public Health       Date:  2022-06-23

Review 3.  Fragment-based screening with natural products for novel anti-parasitic disease drug discovery.

Authors:  Miaomiao Liu; Ronald J Quinn
Journal:  Expert Opin Drug Discov       Date:  2019-09-12       Impact factor: 6.098

Review 4.  Fragment-to-Lead Medicinal Chemistry Publications in 2020.

Authors:  Iwan J P de Esch; Daniel A Erlanson; Wolfgang Jahnke; Christopher N Johnson; Louise Walsh
Journal:  J Med Chem       Date:  2021-12-20       Impact factor: 7.446

Review 5.  Key Topics in Molecular Docking for Drug Design.

Authors:  Pedro H M Torres; Ana C R Sodero; Paula Jofily; Floriano P Silva-Jr
Journal:  Int J Mol Sci       Date:  2019-09-15       Impact factor: 5.923

6.  Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays.

Authors:  Cristian O Salas; Ana Maria Zarate; Vladimir Kryštof; Jaime Mella; Mario Faundez; Jose Brea; María Isabel Loza; Ivan Brito; Denisa Hendrychová; Radek Jorda; Alan R Cabrera; Ricardo A Tapia; Christian Espinosa-Bustos
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

Review 7.  Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?

Authors:  Sk Abdul Amin; Suvankar Banerjee; Shovanlal Gayen; Tarun Jha
Journal:  Eur J Med Chem       Date:  2021-02-13       Impact factor: 6.514

8.  Discovery of Cofactor Competitive Inhibitors against the Human Methyltransferase Fibrillarin.

Authors:  Yun Shi; Ibrahim M El-Deeb; Veronika Masic; Lauren Hartley-Tassell; Andrea Maggioni; Mark von Itzstein; Thomas Ve
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-24

9.  Development of a Fragment-Based Screening Assay for the Focal Adhesion Targeting Domain Using SPR and NMR.

Authors:  Carlos Alvarado; Erik Stahl; Karissa Koessel; Andrew Rivera; Brian R Cherry; Surya V S R K Pulavarti; Thomas Szyperski; William Cance; Timothy Marlowe
Journal:  Molecules       Date:  2019-09-14       Impact factor: 4.411

10.  Inhibitors of Human Divalent Metal Transporters DMT1 (SLC11A2) and ZIP8 (SLC39A8) from a GDB-17 Fragment Library.

Authors:  Jonai Pujol-Giménez; Marion Poirier; Sven Bühlmann; Céline Schuppisser; Rajesh Bhardwaj; Mahendra Awale; Ricardo Visini; Sacha Javor; Matthias A Hediger; Jean-Louis Reymond
Journal:  ChemMedChem       Date:  2021-08-31       Impact factor: 3.466

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.